137 related articles for article (PubMed ID: 18698001)
1. The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter.
Tilley MR; Gu HH
J Pharmacol Exp Ther; 2008 Nov; 327(2):554-60. PubMed ID: 18698001
[TBL] [Abstract][Full Text] [Related]
2. Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.
Thanos PK; Bermeo C; Rubinstein M; Suchland KL; Wang GJ; Grandy DK; Volkow ND
J Psychopharmacol; 2010 Jun; 24(6):897-904. PubMed ID: 19282420
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter inhibition and 5-HT
Stewart A; Davis GL; Gresch PJ; Katamish RM; Peart R; Rabil MJ; Gowrishankar R; Carroll FI; Hahn MK; Blakely RD
Neuropsychopharmacology; 2019 Apr; 44(5):994-1006. PubMed ID: 30578419
[TBL] [Abstract][Full Text] [Related]
4. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
[TBL] [Abstract][Full Text] [Related]
5. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
[TBL] [Abstract][Full Text] [Related]
6. Dopamine transporter inhibition is required for cocaine-induced stereotypy.
Tilley MR; Gu HH
Neuroreport; 2008 Jul; 19(11):1137-40. PubMed ID: 18596615
[TBL] [Abstract][Full Text] [Related]
7. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
Sora I; Wichems C; Takahashi N; Li XF; Zeng Z; Revay R; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7699-704. PubMed ID: 9636213
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate and its ethanol transesterification metabolite ethylphenidate: brain disposition, monoamine transporters and motor activity.
Williard RL; Middaugh LD; Zhu HJ; Patrick KS
Behav Pharmacol; 2007 Feb; 18(1):39-51. PubMed ID: 17218796
[TBL] [Abstract][Full Text] [Related]
9. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
10. Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.
Ferris MJ; Calipari ES; Mateo Y; Melchior JR; Roberts DC; Jones SR
Neuropsychopharmacology; 2012 Jun; 37(7):1708-16. PubMed ID: 22395730
[TBL] [Abstract][Full Text] [Related]
11. Restoration of cocaine stimulation and reward by reintroducing wild type dopamine transporter in adult knock-in mice with a cocaine-insensitive dopamine transporter.
Wu H; O'Neill B; Han DD; Thirtamara-Rajamani K; Wang Y; Gu HH
Neuropharmacology; 2014 Nov; 86():31-7. PubMed ID: 24835281
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Yamashita M; Fukushima S; Shen HW; Hall FS; Uhl GR; Numachi Y; Kobayashi H; Sora I
Neuropsychopharmacology; 2006 Oct; 31(10):2132-9. PubMed ID: 16407898
[TBL] [Abstract][Full Text] [Related]
13. Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats.
Sellings LH; McQuade LE; Clarke PB
Neuroscience; 2006 Sep; 141(3):1457-68. PubMed ID: 16753267
[TBL] [Abstract][Full Text] [Related]
14. Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine.
Izenwasser S; Coy AE; Ladenheim B; Loeloff RJ; Cadet JL; French D
Eur J Pharmacol; 1999 Jun; 373(2-3):187-93. PubMed ID: 10414438
[TBL] [Abstract][Full Text] [Related]
15. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
Gatley SJ; Volkow ND; Gifford AN; Fowler JS; Dewey SL; Ding YS; Logan J
Psychopharmacology (Berl); 1999 Sep; 146(1):93-100. PubMed ID: 10485970
[TBL] [Abstract][Full Text] [Related]
16. Cocaine reward and locomotion stimulation in mice with reduced dopamine transporter expression.
Tilley MR; Cagniard B; Zhuang X; Han DD; Tiao N; Gu HH
BMC Neurosci; 2007 Jun; 8():42. PubMed ID: 17584943
[TBL] [Abstract][Full Text] [Related]
17. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.
Chen R; Tilley MR; Wei H; Zhou F; Zhou FM; Ching S; Quan N; Stephens RL; Hill ER; Nottoli T; Han DD; Gu HH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9333-8. PubMed ID: 16754872
[TBL] [Abstract][Full Text] [Related]
18. Cocaine does not produce reward in absence of dopamine transporter inhibition.
Tilley MR; O'Neill B; Han DD; Gu HH
Neuroreport; 2009 Jan; 20(1):9-12. PubMed ID: 18987557
[TBL] [Abstract][Full Text] [Related]
19. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
Hall FS; Sora I; Hen R; Uhl GR
PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and norepinephrine transporter inhibition for long-term fear memory enhancement.
Pantoni MM; Carmack SA; Hammam L; Anagnostaras SG
Behav Brain Res; 2020 Jan; 378():112266. PubMed ID: 31580915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
